Surgery technology producer Stryker has paid an undisclosed sum to acquire Gauss Surgical, a similarly US-based peer backed by a host of corporate investors.
Founded in 2011, Gauss has built a computer vision-powered software tool dubbed Triton, which is intended for use in operations helping surgeons detect blood loss.
The company last received funding in October 2020 when it completed a $30m series C round with $10m from dental care provider Delta Dental of Michigan and Ohio’s 4100 Group and SoftBank Ventures Asia, a subsidiary of telecommunications and internet group SoftBank, as well as care providers Northwell Health, OSF Healthcare and Providence Health and Services, and Polaris Partners.
Gauss closed a $20m tranche of the round that included SoftBank Ventures Asia and health systems Northwell Health, Memorial Hermann Health System, UNC/Rex Healthcare, OSF Healthcare, Providence Healthcare, Orlando Health, Spectrum Health and Mount Sinai Health System.
Polaris Partners’ LS Polaris Innovation Fund also took part, as did the Stanford University-backed Stanford-StartX Fund, Promus Ventures, LifeForce Ventures and Jump Capital.
Northwell and Memorial Hermann invested directly while the other care providers were represented respectively by Rex Health Ventures, OSF Ventures, Providence Ventures, Orlando Health Ventures, Spectrum Health Ventures and Mount Sinai Ventures.
Providence Ventures had joined Summation Health Ventures, a vehicle for care providers MemorialCare Health System and Cedars-Sinai Health System, to provide $12.6m in series B funding for Gauss in 2016.
Summation had chipped into the company’s $12m series A round, in 2015, which was led by Promus and which also featured LifeForce Ventures. Its shareholders additionally included Taube Investment Partners and various private investors.
